Molly Harper insider trades

Open-market stock purchases and sales by Molly Harper, Director at Catalyst Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 28, 2021.

Recent trades

DateStockTradeValue
Dec 29, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Dec 12, 2025CPRX Catalyst Pharmaceuticals, IncSold$360K
Dec 12, 2025CPRX Catalyst Pharmaceuticals, IncSold$106K
Dec 12, 2025CPRX Catalyst Pharmaceuticals, IncSold$156K
Dec 12, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Dec 8, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 21, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 20, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 20, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—

Companies traded

  • CPRX Catalyst Pharmaceuticals, Inc: 7 sales, last Dec 29, 2025

Get free alerts when Molly Harper files a new trade →